About Us

The story begins with a passion for the plant and mother nature. It´s unique ability to supply us with naturally grown medicine, without chemicals.

We feel that the area of Medicinal Cannabis is now only beginning to scratch the surface of what is possible, and how many uses it can be purposed for.  We are excited to be able to assist in mapping some of these possibilities, for the betterment of all.

We are devoted to producing the highest possible quality Medicinal Cannabis products, using the most efficient state-of-the-art equipment, knowledge, and most importantly with respect for the plant.

Real Canna Seeds seeks out rare plant genetics in a never-ending quest to discover new genetic material, and learn new properties.

From exotic origins, we move to the scientific plant cultivation and mapping of genetics. Our team’s expertise combined with state-of-the-art proprietary technology at our high-care grow facility results in a medical-grade product of the highest possible quality.

This also positions us to be able to collaborate with global brands through strategic joint ventures and partnerships.

Real Canna Seeds Plc is on the road to the world of GMP* pharmaceutical-grade cannabis seeds, produced in a high care facility in Denmark.

The market is ready for an institutional-level seed supplier with the knowledge and experience to deliver a pharmaceutical-grade product GMP certified, and the discipline to ensure organizational sustainability through compliance and the consistent application of the highest industry standards.

* (Good Manufacturing Practice)

Good manufacturing practice (GMP) describes the minimum standard that a medicines manufacturer must meet in their production processes. The European Medicines Agency (EMA) coordinates inspections to verify compliance with these standards and plays a key role in harmonizing GMP activities at European Union (EU) level.

Any manufacturer of medicines intended for the EU market, no matter where in the world it is located, must comply with GMP.

GMP requires that medicines:
– are of consistently high quality;
– are appropriate for their intended use;
– meet the requirements of the marketing authorization or clinical trial authorization.